Showing results (441-450 of 541) with videos related to

Sort By:
Pageof 55
Liver Cancer|April 26, 2019
Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib TreatmentLi-Chun Lu, Yi-Hsuan Lee, Chun-Jung Chang, et al.
Liver Cancer|July 11, 2020
Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational StudyZhexuan Wang, Enxin Wang, Wei Bai, et al.
Liver Cancer|July 11, 2020
Development and Validation of a Nomogram for Patients with Nonmetastatic BCLC Stage C Hepatocellular Carcinoma after Stereotactic Body RadiotherapyWen-Yen Huang, Chiao-Ling Tsai, Jenny Y Que, et al.
Liver Cancer|November 27, 2019
Locoregional Therapy, Immunotherapy and the Combination in Hepatocellular Carcinoma: Future DirectionsMeaghan S Dendy, Johannes M Ludwig, Stacey M Stein, et al.
Liver Cancer|November 27, 2019
Prediction of Prognosis of Intermediate-Stage HCC Patients: Validation of the Tumor Marker Score in a Nationwide Database in JapanAtsushi Hiraoka, Kojiro Michitaka, Takashi Kumada, et al.
Liver Cancer|December 5, 2019
Systemic Treatment Options in Hepatocellular CarcinomaLorenza Rimassa, Tiziana Pressiani, Philippe Merle
Liver Cancer|December 5, 2019
Sorafenib: Experience and Better Manage-ment of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective AnalysisJean-Luc Raoul, Xavier Adhoute, Guillaume Penaranda, et al.
Liver Cancer|December 5, 2019
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular CarcinomaLi-Chun Lu, Chiun Hsu, Yu-Yun Shao, et al.
Liver Cancer|November 30, 2018
The Prognosis of Single Large Hepatocellular Carcinoma Was Distinct from Barcelona Clinic Liver Cancer Stage A or B: The Role of Albumin-Bilirubin GradeKuan-Chieh Fang, Wei-Yu Kao, Chien-Wei Su, et al.
Liver Cancer|June 11, 2025
Survival Benefit of Hepatectomy after Complete or Partial Response to Conversion Therapy in Unresectable Hepatocellular Carcinoma (GUIDANCE003): A Multicenter StudyDa-Long Yang, Ning Peng, Jun-Liang Nong, et al.
Pageof 55